112 related articles for article (PubMed ID: 21658836)
1. Current management of endometrial hyperplasia-a survey of United Kingdom consultant gynaecologists.
Gallos ID; Ofinran O; Shehmar M; Coomarasamy A; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):305-7. PubMed ID: 21658836
[TBL] [Abstract][Full Text] [Related]
2. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
[TBL] [Abstract][Full Text] [Related]
3. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
[TBL] [Abstract][Full Text] [Related]
4. Management of Endometrial Hyperplasia: A Survey of Members of the Korean Gynecologic Oncology Group.
Kim MK; Seong SJ; Kim JW; Bae DS; Jeon S; Kwon SH; Lee TS
Int J Gynecol Cancer; 2015 Sep; 25(7):1277-84. PubMed ID: 26067858
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
El Behery MM; Saleh HS; Ibrahiem MA; Kamal EM; Kassem GA; Mohamed Mel S
Reprod Sci; 2015 Mar; 22(3):329-34. PubMed ID: 25001020
[TBL] [Abstract][Full Text] [Related]
7. Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.
Ercan CM; Duru NK; Sakinci M; Alanbay I; Karasahin KE; Baser I
Gynecol Endocrinol; 2010 Feb; 26(2):125-8. PubMed ID: 20074021
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Bian J; Shao H; Liu H; Li H; Fang L; Xing C; Wang L; Tao M
Reprod Sci; 2015 Jun; 22(6):758-66. PubMed ID: 25536958
[TBL] [Abstract][Full Text] [Related]
9. Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort study.
Gallos ID; Devey J; Ganesan R; Gupta JK
Gynecol Oncol; 2013 Jul; 130(1):58-63. PubMed ID: 23603367
[TBL] [Abstract][Full Text] [Related]
10. Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia.
Ewies AA; Alfhaily F
Obstet Gynecol Surv; 2012 Nov; 67(11):726-33. PubMed ID: 23151756
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia.
Shen Y; Fang H; Zhang Y; Du Y; Cai R; Zhao M; Chen Q
Heliyon; 2022 Dec; 8(12):e12150. PubMed ID: 36561678
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
13. Guideline No. 390-Classification and Management of Endometrial Hyperplasia.
Auclair MH; Yong PJ; Salvador S; Thurston J; Colgan TTJ; Sebastianelli A
J Obstet Gynaecol Can; 2019 Dec; 41(12):1789-1800. PubMed ID: 31785798
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
Haoula ZJ; Walker KF; Powell MC
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):176-9. PubMed ID: 21741152
[TBL] [Abstract][Full Text] [Related]
15. The management of endometrial hyperplasia: an evaluation of current practice.
Clark TJ; Neelakantan D; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):259-64. PubMed ID: 16246481
[TBL] [Abstract][Full Text] [Related]
16. [Effects of levonorgestrel-releasing intrauterine system on endometrial estrogen and progesterone receptors in patients with endometrial hyperplasia].
Weng M; Li L; Feng S; Xie M; Hong S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1350-4. PubMed ID: 22985581
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.
Wildemeersch D; Janssens D; Pylyser K; De Wever N; Verbeeck G; Dhont M; Tjalma W
Maturitas; 2007 Jun; 57(2):210-3. PubMed ID: 17270370
[TBL] [Abstract][Full Text] [Related]
18. How do UK gynaecologists manage endometrial carcinoma? A national survey.
Rogerson L; Downes E
Eur J Gynaecol Oncol; 1998; 19(4):331-2. PubMed ID: 9744719
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical study.
Akesson E; Gallos ID; Ganesan R; Varma R; Gupta JK
Acta Obstet Gynecol Scand; 2010 Mar; 89(3):393-8. PubMed ID: 20199355
[TBL] [Abstract][Full Text] [Related]
20. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
